https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
156
 
downloads
65
CITE
How to cite this poster:
Farrugia A, Bansal M and Cassar J Effect of pharmacokinetic dosage and inhibitor incidence on the cost utility of life-long prophylaxis in haemophilia A. F1000Posters 2013, 4:147 (poster)

Effect of pharmacokinetic dosage and inhibitor incidence on the cost utility of life-long prophylaxis in haemophilia A

Albert Farrugia1, M Bansal, J Cassar
Published 04 Apr 2013
Author Affiliations
  • Metrics
  • 156 Views
  • 65 Downloads
Browse by related subjects
Published 04 Apr 2013

Effect of pharmacokinetic dosage and inhibitor incidence on the cost utility of life-long prophylaxis in haemophilia A

[version 1; not peer reviewed]

Albert Farrugia1, M Bansal, J Cassar
Author Affiliations
1 School of Medicine, Australian National University, Australia
Presented at
6th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) 2013
Abstract
Competing Interests

Compensated consulting for the manufacturers of haemophilia therapies.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.